NICE agrees to reconsider beta-interferon proposals.
Scott
G
G
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D006801:Humans; D016899:Interferon-beta / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D013222:State Medicine; D006113:United Kingdom
D000276:Adjuvants, Immunologic; D016899:Interferon-beta